feed,title,long_url,short_url
Benzinga,"Celldex's Barzolvolimab Shows Rapid, Durable Responses In Early Urticaria Study",https://benzinga.com/general/biotech/22/07/27931602/celldexs-barzolvolimab-shows-rapid-durable-responses-in-early-urticaria-study,https://bit.ly/3nx1ZNn
